Clinical characteristics of null responders to Peg-IFNα2b/ribavirin therapy for chronic hepatitis C

AIM: To predict which chronic hepatitis C patients are likely to be late-responders, we herein investigated the clinical characteristics of null-responders at 36 wk with hepatitis C virus (HCV) genotype Ib and a high viral load during the course of pegylated interferon (Peg-IFN)/ribavirin therapy. M...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Suzuki, Hideyuki, Kakizaki, Satoru, Horiguchi, Norio, Ichikawa, Takeshi, Sato, Ken, Takagi, Hitoshi, Mori, Masatomo
Natura: Artigo
Lingua:Inglês
Pubblicazione: Baishideng Publishing Group Co., Limited 2010
Soggetti:
Brief Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC3004033/
https://ncbi.nlm.nih.gov/pubmed/21173908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v2.i11.401
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi